Literature DB >> 18765413

Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus.

Xavier Malaviolle1, Claire Nonhoff, Olivier Denis, Sylvianne Rottiers, Marc J Struelens.   

Abstract

OBJECTIVES: To compare the performance of the automated Vitek 2 system, the disc diffusion method and a home-made mupirocin screen agar (MSA) to detect mupirocin resistance in methicillin-resistant Staphylococcus aureus (MRSA) isolates.
METHODS: A total of 125 MRSA isolates were tested. The level of mupirocin resistance was determined by agar dilution and Etest techniques (gold standard), by the Vitek 2 system, on MSA (Mueller-Hinton + mupirocin 4 mg/L) and with the disc diffusion method using 10 microg mupirocin Neo-Sensitabs (MUP-10) and mupirocin paper discs of 5, 20 and 200 microg (MUP-5, MUP-20 and MUP-200). High-level mupirocin resistance (HLMR) was confirmed by PCR for the mupA gene.
RESULTS: Thirty-two MRSA isolates showed HLMR (MIC > or = 512 mg/L) and harboured the mupA gene, 39 strains showed low-level mupirocin resistance (LLMR) (8-32 mg/L) without the mupA gene and 54 were susceptible without the mupA gene. The sensitivity and the specificity of the Vitek 2 system and the screening medium (MSA) for the detection of mupirocin resistance was 100%. The diffusion method using 5 and 10 microg discs demonstrated a sensitivity of 100% and a specificity of 98.1% and 100%, respectively. Using interpretative criteria of 6 and 17 mm, the MUP-20 disc showed the best classification concordance with reference methods.
CONCLUSIONS: The diffusion method using low-content discs or the Vitek 2 microdilution system showed excellent agreement with MICs and PCR results to separate mupirocin-susceptible from -resistant MRSA strains. Disc diffusion with MUP-20 or combined use of low and high mupirocin content discs enabled the classification of susceptibility categories (susceptible, LLMR and HLMR) but required overnight incubation compared with 12 h for the Vitek 2 system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765413     DOI: 10.1093/jac/dkn345

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents.

Authors:  Jennifer S McDanel; Courtney R Murphy; Daniel J Diekema; Victor Quan; Diane S Kim; Ellena M Peterson; Kaye D Evans; Grace L Tan; Mary K Hayden; Susan S Huang
Journal:  Antimicrob Agents Chemother       Date:  2012-11-12       Impact factor: 5.191

Review 2.  Resistance to and synthesis of the antibiotic mupirocin.

Authors:  Christopher M Thomas; Joanne Hothersall; Christine L Willis; Thomas J Simpson
Journal:  Nat Rev Microbiol       Date:  2010-03-01       Impact factor: 60.633

3.  Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use.

Authors:  Erik Bathoorn; David J Hetem; Jeriela Alphenaar; Johannes G Kusters; Marc J M Bonten
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

4.  Evaluation of mupA Evigene in comparison to disk diffusion for detection of high-level mupirocin resistance in clinical isolates of Staphylococcus aureus.

Authors:  Carlos Acuna-Villaorduna; Matthew J Hardwick; Suzanne Goucher; Masashi Waga; Shmuel Shoham
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

5.  Comparative Performances of Vitek-2, Disk Diffusion, and Broth Microdilution for Antimicrobial Susceptibility Testing of Canine Staphylococcus pseudintermedius.

Authors:  Elisa Rampacci; Michele Trotta; Caterina Fani; Serenella Silvestri; Valentina Stefanetti; Chiara Brachelente; Antonella Mencacci; Fabrizio Passamonti
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

6.  Is the Colonisation of Staphylococcus aureus in Pets Associated with Their Close Contact with Owners?

Authors:  Karolina Bierowiec; Katarzyna Płoneczka-Janeczko; Krzysztof Rypuła
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.